Skip to Main Content

Advertisement

Close

AACR Journals
For Authors
About Us
Article Collections
COVID-19
Webinars

header search

search input Search input auto suggest

Search

Advanced Search

Menu

About
Articles
For Authors
Alerts
News
COVID-19
Webinars

Skip Nav Destination

Issues

Select Year

Issue

Volume 3, Issue 7

1 July 1997

Front Matter
Table of Contents
Back Matter
Editorial Board

ISSN 1078-0432

EISSN 1557-3265

Issue Sections

Minireview
Research Articles

Minireview

Pharmacogenetics in cancer etiology and chemotherapy.

A V Boddy; M J Ratain

Research Articles

Long-lasting complete inhibition of human solid tumors in SCID mice by targeting endothelial cells of tumor vasculature with antihuman endoglin immunotoxin.

B K Seon; F Matsuno; Y Haruta; M Kondo; M Barcos

Loss of KAI1 messenger RNA expression in both high-grade and invasive human bladder cancers.

Y Yu; J L Yang; B Markovic; P Jackson; G Yardley; J Barrett; P J Russell

Prognostic significance of cyclin D1 and retinoblastoma expression in combination with p53 abnormalities in primary, resected non-small cell lung cancers.

M Nishio; T Koshikawa; Y Yatabe; T Kuroishi; M Suyama; M Nagatake; T Sugiura; Y Ariyoshi; T Mitsudomi; T Takahashi

Analysis of transforming growth factor (TGF)-alpha/epidermal growth factor receptor, hepatocyte growth Factor/c-met,TGF-beta receptor type II, and p53 expression in human hepatocellular carcinomas.

A Kiss; N J Wang; J P Xie; S S Thorgeirsson

Changes in DNA copy number in primary gastric carcinomas by comparative genomic hybridization.

Y Koizumi; S i Tanaka; R Mou; H Koganei; A Kokawa; R Kitamura; H Yamauchi; K Ookubo; T Saito; S Tominaga; K Matsumura; H Shimada; N Tsuchida; H Sekihara

Phase IB clinical trial of the oligosaccharide processing inhibitor swainsonine in patients with advanced malignancies.

P E Goss; C L Reid; D Bailey; J W Dennis

Limited sampling model for the area under the concentration versus time curve of irinotecan and its application to a multicentric phase II trial.

N Yamamoto; T Tamura; Y Nishiwaki; Y Kurita; Y Kawakami; S Abe; T Nakabayashi; S Suzuki; T Matsuda; I Hayashi; T Takahashi; N Saijo

Phase I trial of temozolomide (NSC 362856) in patients with advanced cancer.

M Dhodapkar; J Rubin; J M Reid; P A Burch; H C Pitot; J C Buckner; M M Ames; V J Suman

Endocrine and clinical effects of exemestane (PNU 155971), a novel steroidal aromatase inhibitor, in postmenopausal breast cancer patients: a phase I study.

D C Johannessen; T Engan; E Di Salle; M G Zurlo; J Paolini; G Ornati; G Piscitelli; S Kvinnsland; P E Lonning

A phase I study of high-dose tamoxifen for the treatment of refractory malignant gliomas of childhood.

I F Pollack; R C DaRosso; P L Robertson; R L Jakacki; J R Mirro, Jr; J Blatt; S Nicholson; R J Packer; J C Allen; A Cisneros; V C Jordan

A phase I trial of paclitaxel plus carboplatin in untreated patients with advanced non-small cell lung cancer.

K Kelly; Z Pan; J Murphy; D H Huffman; P A Bunn, Jr

A pilot study of gamma-1b-interferon in combination with fluorouracil, leucovorin, and alpha-2a-interferon.

J L Grem; N McAtee; R F Murphy; F M Balis; E Cullen; A P Chen; J M Hamilton; S M Steinberg; M Quinn; J M Sorensen; S G Arbuck; D Lawrence; J Pang; C J Allegra

Virus potentiation of tumor vaccine T-cell stimulatory capacity requires cell surface binding but not infection.

V Schirrmacher; C Haas; R Bonifer; C Ertel

Radiosensitization of human tumor cells by the phosphatidylinositol3-kinase inhibitors wortmannin and LY294002 correlates with inhibition of DNA-dependent protein kinase and prolonged G2-M delay.

K E Rosenzweig; M B Youmell; S T Palayoor; B D Price

Pharmacological basis for a novel therapeutic strategy based on the use of aquated cisplatin.

H Zheng; D Fink; S B Howell

Inhibition of platelet-derived growth factor-mediated signal transduction and tumor growth by N-[4-(trifluoromethyl)-phenyl]5-methylisoxazole-4-carboxamide.

L K Shawver; D P Schwartz; E Mann; H Chen; J Tsai; L Chu; L Taylorson; M Longhi; S Meredith; L Germain; J S Jacobs; C Tang; A Ullrich; M E Berens; E Hersh; G McMahon; K P Hirth; T J Powell

Antitumor activity of a C-raf antisense oligonucleotide in combination with standard chemotherapeutic agents against various human tumors transplanted subcutaneously into nude mice.

T Geiger; M Müller; B P Monia; D Fabbro

Adenoviral-mediated delivery of gastrin-releasing peptide receptor results in specific tumor localization of a bombesin analogue in vivo.

M E Rosenfeld; B E Rogers; M B Khazaeli; G Mikheeva; D Raben; M S Mayo; D T Curiel; D J Buchsbaum

The utility of p53 immunostaining of transbronchial biopsy specimens of lung cancer: p53 overexpression predicts poor prognosis and chemoresistance in advanced non-small cell lung cancer.

M Kawasaki; Y Nakanishi; K Kuwano; J Yatsunami; K Takayama; N Hara

Expression of the prostate specific antigen gene by lung tissue.

N Zarghami; M D'Costa; D Tsuyuki; S L Asa; E P Diamandis

Comparison of oncogene mutation detection and telomerase activity for the molecular staging of non-small cell lung cancer.

S A Ahrendt; S C Yang; L Wu; W H Westra; J Jen; J A Califano; D Sidransky

Combined nested reverse transcription-PCR assay for prostate-specific antigen and prostate-specific membrane antigen in detecting circulating prostatic cells.

Y Zhang; C D Zippe; F Van Lente; E A Klein; M K Gupta

Clinical investigation of neuroblastoma with partial deletion in the short arm of chromosome 1.

K Ohtsu; E Hiyama; T Ichikawa; Y Matsuura; T Yokoyama

Microsatellite alterations at 5q21, 11p13, and 11p15.5 do not predict survival in non-small cell lung cancer.

M Sánchez-Céspedes; R Rosell; A Pifarré; M P López-Cabrerizo; A Barnadas; J J Sánchez; J C Lorenzo; A Abad; M Monzó; J J Navas-Palacios

Advertisement

Email alerts

Online First Alert

eTOC Alert

Latest
Most Read
Most Cited

Pertuzumab, Trastuzumab, and an Aromatase Inhibitor for HER2-Positive and Hormone Receptor-Positive Metastatic/Locally Advanced Breast Cancer: PERTAIN Final Analysis

NPY methylated ctDNA is a promising biomarker for treatment response monitoring in metastatic colorectal cancer

CEACAM1 marks highly suppressive intratumoral regulatory T cells for targeted depletion therapy

Phase I Study and Cell-Free DNA Analysis of T-DM1 and Metronomic Temozolomide for Secondary Prevention of HER2-Positive Breast Cancer Brain Metastases

Issues
Online First
Collections

News
Twitter

Online ISSN 1557-3265
Print ISSN 1078-0432

AACR Journals

Blood Cancer Discovery
Cancer Discovery
Cancer Epidemiology, Biomarkers, & Prevention
Cancer Immunology Research
Cancer Prevention Research
Cancer Research
Cancer Research Communications
Clinical Cancer Research
Molecular Cancer Research
Molecular Cancer Therapeutics

Info for Advertisers
Info for Librarians
Privacy Policy

Twitter
LinkedIn
Facebook
Youtube

Copyright © 2022 by the American Association for Cancer Research.

This Feature Is Available To Subscribers Only

Sign In or Create an Account

This site uses cookies. By continuing to use our website, you are agreeing to our privacy policy.

Accept